Profund Advisors LLC Beam Therapeutics Inc. Transaction History
Profund Advisors LLC
- $2.67 Billion
- Q4 2024
A detailed history of Profund Advisors LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 22,111 shares of BEAM stock, worth $505,678. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,111
Previous 36,987
40.22%
Holding current value
$505,678
Previous $906,000
39.51%
% of portfolio
0.02%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding BEAM
# of Institutions
253Shares Held
78.6MCall Options Held
304KPut Options Held
142K-
Farallon Capital Management LLC San Francisco, CA8.24MShares$188 Million1.09% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$175 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.62MShares$174 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$162 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$104 Million70.85% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.61B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...